Stephen W. Hunt

ATR-101, a Selective and Potent Inhibitor of Acyl-CoA Acyltransferase 1, Induces Apoptosis in H295R Adrenocortical Cells and in the Adrenal Cortex of Dogs.

G. Hammer, W. Rainey, V. Crudo, 2016, Endocrinology.

ATR-101, a selective ACAT1 inhibitor, decreases ACTH-stimulated cortisol concentrations in dogs with naturally occurring Cushing’s syndrome

P. Pearson, W. Schall, R. Smedley, 2018, BMC Endocrine Disorders.

Pepducins: lipopeptide allosteric modulators of GPCR signaling.

T. McMurry, K. Carlson, Stephen W. Hunt, 2012, Drug discovery today. Technologies.

Vanilloid Receptor TRPV1, Sensory C-Fibers, and Vascular Autoregulation: A Novel Mechanism Involved in Myogenic Constriction

A. Ahluwalia, S. Chauhan, C. de Felipe, 2004, Circulation research.

Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein

J. Benovic, M. Bouvier, V. Lukashova, 2013, Proceedings of the National Academy of Sciences.

Direct interaction between an allosteric agonist pepducin and the chemokine receptor CXCR4.

Pallavi Sachdev, Tom W Muir, Christoph Seibert, 2011, Journal of the American Chemical Society.

Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells

Pallavi Sachdev, T. Sakmar, M. Kazmi, 2010, Proceedings of the National Academy of Sciences.

Vanilloid Receptor TRPV1, Sensory C-Fibers, and Vascular Autoregulation: A Novel Mechanism Involved in Myogenic Constriction

A. Ahluwalia, S. Chauhan, C. de Felipe, 2004, Circulation research.

Can precision medicine reduce overdiagnosis?

S. Jha, Stephen W. Hunt, 2015, Academic radiology.